PHI with Paralysis agitans
How does this condition affect your private health insurance?
Paralysis agitans, commonly known as Parkinson's disease, is a progressive neurodegenerative disorder affecting dopamine-producing neurons in the brain. It primarily manifests with motor symptoms such as tremor, rigidity, bradykinesia (slow movement), and postural instability. Non-motor symptoms, including cognitive impairment, mood disorders, sleep disturbances, and autonomic dysfunction, often precede or accompany motor signs, significantly impacting quality of life. The exact cause is largely unknown, but a combination of genetic and environmental factors is believed to play a role. Management focuses on symptomatic relief and slowing disease progression.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Subtle, gradual onset, often unrecognized for several months to a few years as symptoms are mild and non-specific.
Duration of Illness (Lifetime)
Chronic, progressive, lifelong disease.
Cost of Treatment (Initial)
Initial diagnosis and early medication: typically several thousands to tens of thousands of dollars annually, varying significantly by region and healthcare system.
Cost of Treatment (Lifetime)
Significant, ranging from hundreds of thousands to well over a million dollars, encompassing medication, therapies (physical, occupational, speech), potential surgeries (e.g., Deep Brain Stimulation), and long-term care.
Mortality Rate
Increased risk of death due to complications such as pneumonia, falls, and dysphagia, typically reducing life expectancy by several years compared to the general population, but not a direct cause of death itself.
Risk of Secondary Damages
Very high (>80-90%). Common secondary damages include motor fluctuations, dyskinesia, cognitive decline (dementia), mood disorders (depression, anxiety), sleep disorders, autonomic dysfunction, falls, and significantly impaired quality of life.
Probability of Full Recovery
Extremely low (virtually 0%), as it is a progressive neurodegenerative disease with no known cure.
Underlying Disease Risk
Common comorbidities include depression, anxiety, sleep disorders, and constipation. It's also important to rule out other parkinsonian syndromes (e.g., Multiple System Atrophy, Progressive Supranuclear Palsy) at the time of diagnosis.